ERBB2 and breast carcinoma: Furthermore, breast cancers can be classified using surrogate immunohistochemistry markers, namely oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and antigen KI‐67 (Ki‐67).5